Product
HB-adMSC
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
A Randomized, Placebo-Controlled, Double-Blind, Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19Status: Terminated, Estimated PCD: 2021-09-30